Peijian Peng

Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial

Li Zhang, Yan Huang, Shaodong Hong et al. · The Lancet · 2016 · 515 citations

Cisplatin Versus Fluorouracil, Medicine, Metronomic Therapy +6

KRAS mutation-induced upregulation of PD-L1 mediates immune escape in human lung adenocarcinoma

Nan Chen, Wenfeng Fang, Lin Zhong et al. · Cancer Immunology Immunotherapy · 2017 · 287 citations · Full text

The association between PD-L1 and EGFR status and the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs

Yanna Tang, Wenfeng Fang, Yaxiong Zhang et al. · Oncotarget · 2015 · 241 citations · Full text

Gemcitabine Plus Cisplatin Versus Fluorouracil Plus Cisplatin as First-Line Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: Final Overall Survival Analysis of GEM20110714 Phase III Study

Shaodong Hong, Yaxiong Zhang, Gengsheng Yu et al. · Journal of Clinical Oncology · 2021 · 95 citations · Full text

Low Prognostic Nutritional Index (PNI) Predicts Unfavorable Distant Metastasis-Free Survival in Nasopharyngeal Carcinoma: A Propensity Score-Matched Analysis

Lin Yang, Liangping Xia, Yan Wang et al. · PLoS ONE · 2016 · 72 citations · Full text